Hilversum, Netherlands

Petronella Johanna Maria Van Dongen


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Petronella Johanna Maria Van Dongen: Innovator in Parkinson's Disease Treatment

Introduction

Petronella Johanna Maria Van Dongen is a notable inventor based in Hilversum, Netherlands. He has made significant contributions to the field of medical research, particularly in the treatment of Parkinson's disease. His innovative work has led to the development of a unique compound that holds promise for therapeutic applications.

Latest Patents

Van Dongen holds a patent for the "Use of indole derivatives as NURR-1 activators for treating Parkinson's disease." This invention relates to a compound derived from indole, specifically a therapeutically useful compound characterized by its selection from compounds of a defined formula. This patent represents a significant advancement in the search for effective treatments for Parkinson's disease.

Career Highlights

Throughout his career, Van Dongen has focused on the intersection of chemistry and medicine. His work has been instrumental in advancing the understanding of how certain compounds can activate NURR-1, a nuclear receptor that plays a crucial role in the development and maintenance of dopaminergic neurons. This research is vital for developing new therapeutic strategies for neurodegenerative diseases.

Collaborations

Van Dongen has collaborated with esteemed colleagues, including Benaïssa Boubia and Johannes Bernard Van Vliet. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the medical field.

Conclusion

Petronella Johanna Maria Van Dongen's contributions to the treatment of Parkinson's disease through his innovative patent highlight the importance of research in developing new therapeutic options. His work exemplifies the potential of scientific innovation to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…